Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer

NCT03240016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Pembrolizumab
DRUG: Abraxane

Sponsor

University of Michigan Rogel Cancer Center